Avalon Globocare CorpAvalon Globocare Corp - ESG Rating & Company Profile powered by AI

Industry Group:Biotechnology & Medical Research

This ESG rating covers 17 UN SDGs including: 'Clean Water & Sanitation', 'Responsible Production & Consumption' and 'Peace, Justice & Strong Institutions'. Detailed Sustainability analysis of Avalon Globocare Corp are reached by registering for free. The page contains a zero-cost Sustainability analysis for Avalon Globocare Corp.

Avalon Globocare Corp in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 6.0, social score of 4.0 and governance score of 6.9.

SDG Transparency Score for Avalon Globocare Corp 
Low
0 - 3

5.6

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Avalon Globocare Corp 
6.0

Environmental

4.0

Social

6.9

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Analytik Jena AG
8.0
High
1Adagio Therapeutics Inc
8.0
High
58Fluicell AB
5.7
High
58Tali Digital Ltd
5.7
High
60Avalon Globocare Corp
5.6
High
60Grail Inc
5.6
High
60Brii Biosciences Ltd
5.6
High
.........
233XLR Medical Corp
0.0
Low
233rEVO Biologics Inc
0.0
Low
.........
View the full peer group of 404 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Avalon Globocare Corp have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Avalon Globocare Corp report the average age of the workforce?

LockedSign up for free to unlock

Does Avalon Globocare Corp reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose cybersecurity risks?

LockedSign up for free to unlock

Does Avalon Globocare Corp offer flexible work?

LockedSign up for free to unlock

Does Avalon Globocare Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Avalon Globocare Corp conduct supply chain audits?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Avalon Globocare Corp conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose water use targets?

LockedSign up for free to unlock

Does Avalon Globocare Corp have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Avalon Globocare Corp have a product recall in the last two years?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose incidents of discrimination?

LockedSign up for free to unlock

Does Avalon Globocare Corp allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Avalon Globocare Corp issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose parental leave metrics?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Avalon Globocare Corp support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Avalon Globocare Corp reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Avalon Globocare Corp involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose its waste policy?

LockedSign up for free to unlock

Does Avalon Globocare Corp report according to TCFD requirements?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose energy use targets?

LockedSign up for free to unlock

Does Avalon Globocare Corp disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Avalon Globocare Corp have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Avalon Globocare Corp
These potential risks are based on the size, segment and geographies of the company.

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.

Sorry!

Failed to process!